Skip to Main Content

Paper Details

Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
mSphere
55
2020
Author NameAffiliation
Irene LuiDepartment of Pharmaceutical Chemistry, University of California san francisco
Charles Y ChiuUniversity of California san francisco
Charles Y ChiuUniversity of California san francisco
Michael R WilsonWeill Institute for Neurosciences, University of California san francisco
Michael R WilsonUniversity of California san francisco
James A WellsDepartment of Pharmaceutical Chemistry, University of California san francisco
James A Wells
James A WellsUniversity of California san francisco
  • 1 - 8

Datasets

Release 1.2